150
Participants
Start Date
March 31, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
June 30, 2027
Nafarelin nasal spray
NAFARLIN 200 MCG X2 DAY
Utrogestan®
UTROGESTAN 200 MG X2 DAY
Shaare Zedek Medical Center
OTHER